Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Articolo

Data di Pubblicazione:

2008

Tipologia CRIS:

1.1 Articolo in rivista

Elenco autori:

Mikol, Dd; Barkhof, F; Chang, P; Coyle, Pk; Jeffery, Dr; Schwid, Sr; Stubinski, B; Utidehaag, Bm; Comi, Giancarlo

Link alla scheda completa:

https://iris.unisr.it/handle/20.500.11768/5804

Pubblicato in:

LANCET NEUROLOGY

Journal